Evidence map›Paper›PMID 38528974›Full record

ArticleFrontiers in psychiatry2024

World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys.

Hamed Ekhtiari, Arash Khojasteh Zonoozi, Parnian Rafei, Fateme Sadat Abolghasemi, Dan Pemstein, Tarek Abdelgawad, Sophia Achab, Hamad Al Ghafri, Mustafa Al'Absi, Michaël Bisch and 40 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors.

Hamed EkhtiariDepartment of Psychiatry, University of Minnesota, Minneapolis, MN, United States.
Arash Khojasteh ZonooziIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Parnian RafeiTrinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland.
Fateme Sadat AbolghasemiIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Dan PemsteinPolitical Science and Public Policy & Challey Institute, North Dakota State University, Fargo, ND, United States.
Tarek AbdelgawadFaculty of Medicine, Cairo University, Cairo, Egypt.
Sophia AchabFaculty of Medicine, Sociological and Psychological Research Unit, Department of Psychiatry, University of Geneva, Geneva, Switzerland.
Hamad Al GhafriNational Rehabilitation Center, Abu Dhabi, United Arab Emirates.
Mustafa Al'AbsiDepartment of Psychiatry, University of Minnesota, Minneapolis, MN, United States.
Michaël BischPôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France.
Aldo Alberto ContiDepartment of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Atul AmbekarNational Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
Shalini ArunogiriMonash Addiction Research Centre, Eastern Health Clinical School, Melbourne, VIC, Australia.
Roshan BhadNational Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
Rabia BiliciFaculty of Medicine, Department of Psychology, Istanbul Ticaret University, Istanbul, Türkiye.
Kathleen BradyDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.
Gregory BuntSchool of Medicine, New York University, New York City, NY, United States.
Anja BussePrevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC), Vienna, Austria.
Jenna L ButnerDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
Ahmad DaneshDivision of Prevention Science, University of California, San Francisco, San Francisco, CA, United States.
Joseph El-KhouryLebanese Psychiatric Society, Beirut, Lebanon.
Fatima El OmariFaculty of Medicine, University Mohammed Vth of Rabat, Rabat, Morocco.
Darius JokūbonisRepublican Center for Addictive Disorders, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Cor de JongBehavioral Science Institute, Radboud University, Nijmegen, Netherlands.
Geert DomCollaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium.
Mohsen EbrahimiIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Ali Fathi JouzdaniIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Marica FerriEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
Susanna Galea-SingerDigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom.
Dario Gigena ParkerSchool of Public Health, National University of Cordoba, Cordoba, Argentina.
Susumu HiguchiNational Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan.
Preethy KathiresanDepartment of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Emira KhelifaFaculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Christos KouimtsidisNational Office for Addressing Drugs, Athens, Greece.
Evgeny M KrupitskyDepartment of Addictions, Bekhterev National Medical Research Center for Psychiatry and Neurology, St. Petersburg, Russia.
Jiang LongFaculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Icro MaremmaniDepartment of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.
Garrett McGovernIrish Chapter of International Society of Addiction Medicine (IRE-ISAM), Dublin, Ireland.
Hossein Mohaddes ArdabiliIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Afarin Rahimi-MovagharIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Solomon Tshimong RataemaneDepartment of Psychiatry, University of Limpopo, Polokwane, South Africa.
Arshiya SangchooliMelbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia.
Goodman SibekoDepartment of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Anna Maria VellaFoundation for Social Welfare Services (FSWS), Sedqa, Santa Venera, Malta.
Salvador Benjamin D VistaDepartment of Psychiatry and Behavioral Medicine, College of Medicine and Philippines General Hospital, University of the Philippines Manila, Manila, Philippines.
Mehran Zare-BidokyIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.
Min ZhaoShanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Afzal JavedPakistan Psychiatric Research Centre, Fountain House, Lahore, Pakistan.
Marc N PotenzaDepartment of Psychiatry and Child Center, Yale School of Medicine, New Haven, CT, United States.
Alexander Mario BaldacchinoDigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom.

Funding

TRAINEESHIPS IN AIDS PREVENTION STUDIEST32MH019105 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carol Suzanne Camlin, Glenn-Milo Santos · 1989 to 2026
$15.3M
NIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

Addiction medicine is a dynamic field that encompasses clinical practice and research in the context of societal, economic, and cultural factors at the local, national, regional, and global levels. This field has evolved profoundly during the past decades in terms of scopes and activities with the contribution of addiction medicine scientists and professionals globally. The dynamic nature of drug addiction at the global level has resulted in a crucial need for developing an international collaborative network of addiction societies, treatment programs and experts to monitor emerging national, regional, and global concerns. This protocol paper presents methodological details of running longitudinal surveys at national, regional, and global levels through the Global Expert Network of the International Society of Addiction Medicine (ISAM-GEN). The initial formation of the network with a recruitment phase and a round of snowball sampling provided 354 experts from 78 countries across the globe. In addition, 43 national/regional addiction societies/associations are also included in the database. The surveys will be developed by global experts in addiction medicine on treatment services, service coverage, co-occurring disorders, treatment standards and barriers, emerging addictions and/or dynamic changes in treatment needs worldwide. Survey participants in categories of (1) addiction societies/associations, (2) addiction treatment programs, (3) addiction experts/clinicians and (4) related stakeholders will respond to these global longitudinal surveys. The results will be analyzed and cross-examined with available data and peer-reviewed for publication.

Indexed as

addiction medicineelicitationexpertglobalnetworksurvey

Identifiers

PMID38528974
PMCPMC10961370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.